Search Options Stock News and Analysis from Schaeffer's

U.S.-China Relations in Focus Amid Strong Week

https://www.schaeffersresearch.com/content/news/2025/04/25/us-china-relations-in-focus-amid-strong-week

4/25/2025 2:31 PM

Though stocks sold off on Monday amid tensions between President Donald Trump and Federal Reserve Chair Jerome Powell, those concerns were quickly alleviated, with the broader market ultimately see...

2 Blue-Chip Stocks Brushing Off Earnings Beats

https://www.schaeffersresearch.com/content/news/2025/04/24/2-blue-chip-stocks-brushing-off-earnings-beats

4/24/2025 10:45 AM

Pharmaceutical giant Merck & Co Inc (NYSE:MRK) has reversed its premarket lead, down 2% at $77.20 at last glance. The company posted better-than-expected first-quarter results but cut its profit out...

2 Blue-Chip Drug Stocks in Focus Today After Earnings

https://www.schaeffersresearch.com/content/news/2025/02/04/2-blue-chip-drug-stocks-in-focus-today-after-earnings

2/4/2025 10:06 AM

Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers. Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) are both making outsized moves -...

Vaxcyte's Drug Update Pushes 2 Biotech Stocks Lower

https://www.schaeffersresearch.com/content/news/2024/09/03/vaxcytes-drug-update-pushes-2-biotech-stocks-lower

9/3/2024 2:10 PM

Vaxcyte Inc (NASDAQ:PCVX) stock is surging today, after the biotechnology company announced positive study results for its drug designed to prevent invasive pneumococcal disease in adults aged 50 or o...

Options Traders Blast 2 Pharma Socks After Earnings

https://www.schaeffersresearch.com/content/news/2024/07/30/options-traders-blast-2-pharma-socks-after-earnings

7/30/2024 10:12 AM

Pharmaceutical giants Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) today reported second-quarter results. While the former beat top- and bottom-line estimates thanks in part to cancer drug K...

PEOPLE ALSO SEARCH FOR